Abstract:Objective:To assess the clinical value of the abundance of BRAFV600E mutation detected in ultrasound-guided fine needle aspiration samples in predicting cervical lymph node metastasis (LNM) of papillary thyroid carcinoma (PTC).Methods:A total of 1046 patients with pathologically confirmed PTC between January 2020 and December 2020 at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine were collected. Ultrasound-guided fine-needle aspiration samples were collected to determine the abundance of BRAFV600E mutation before surgery. Patients were classified into lymph node metastasis group (n=419) and no lymph node metastasis group (n=627) based on lymph node metastasis. The correlation between clinical characteristics (sex, age, tumor diameter, number of nodes, nodal location, and mutation abundance) and cervical LNM in PTC patients was analyzed using χ2 test or t-test. Multifactorial analysis was performed by binary logistic regression analysis, and the diagnostic efficacy of BRAFV600E mutation abundance in predicting cervical LNM in PTC patients was assessed by constructing receiver operating characteristic (ROC) curves.Results:The proportions of males, patients＜45 years old, patients with tumor maximum diameter ≥1 cm, patients with multiple nodes, and those with multiple bilateral nodes in patients with cervical LNM was significantly higher than those in patients without (32.0% vs 19.9%, 72.1% vs 54.5%, 38.9% vs 19.0%, 25.8% vs 18.0%, and 16.2% vs 10.4%; χ2=19.56, 32.62, 50.63, 9.06, and 7.78; P＜0.001,＜0.001,＜0.001, =0.003, and =0.005, respectively); the abundance of BRAFV600E mutation was significantly higher in PTC patients with cervical LNM than in those without [(32.44±20.23)% vs (27.21±20.82) %, t=-4.29, P＜0.001]. Multifactorial regression analysis suggested that male gender, age, maximum diameter ≥1 cm, multiple nodes, and high abundance of BRAFV600E mutation were independent risk factors for cervical LNM in PTC (OR=1.935, 0.425, 2.578, 1.651, and 2.057, respectively; P＜0.05). The sensitivity, specificity, positive predictive value, negative predictive value, and area under the curve of BRAFV600E mutation abundance in predicting cervical LNM were 48.69%, 65.71%, 48.69%, 65.71%, and 0.574, respectively.Conclusion:The detection of BRAFV600E mutation abundance can provide a reference for clinical decision making in cervical LNM resection in patients with PTC.

Role of Ultrasonographic Features and Quantified BRAFV600E Mutation in Lymph Node Metastasis in Chinese Patients with Papillary Thyroid Carcinoma

Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Cancer with BRAF V600E Mutation.

Associations of the BRAF V600E Mutation with Sonographic Features in Patients with Papillary Thyroid Carcinoma

Use of the BRAF V600E Mutation in Fine-Needle Aspirations of Thyroid Nodules

The Features of Contrast Enhanced Ultrasound and BRAF V600E in Papillary Thyroid Carcinoma.

Value of Share Wave Elastography Combined with BRAFV600E in Predicting Central Lymph Nodes Metastasis of Papillary Thyroid Carcinoma

Conventional Ultrasound, Immunohistochemical Factors and BRAFV600E Mutation in Predicting Central Cervical Lymph Node Metastasis of Papillary Thyroid Carcinoma.

The Clinicopathological Features of BRAF Mutated Papillary Thyroid Cancers in Chinese Patients

Association Between BRAF V600E Mutation and Ultrasound Features in Papillary Thyroid Carcinoma Patients with and Without Hashimoto's Thyroiditis.

Association of BRAF(V600E) Mutation with Ultrasonographic Features and Clinicopathologic Characteristics of Papillary Thyroid Microcarcinoma: A Retrospective Study of 116 Cases

Risk and Prognostic Factors for BRAFV600E Mutations in Papillary Thyroid Carcinoma

BRAFV600E mutation and NIS expression in papillary thyroid carcinomas

Integrating BRAFV600E mutation, ultrasonic and clinicopathologic characteristics for predicting the risk of cervical central lymph node metastasis in papillary thyroid carcinoma

Association Between BRAF and RAS Mutations, and RET Rearrangements and the Clinical Features of Papillary Thyroid Cancer.

Relationship between BRAF V600E mutation, cervical lymph node metastases and extrathyroidal ;extension in papillary thyroid carcinoma

BRAFV600E mutation abundance determined based on ultrasound-guided fine needle aspiration samples for predicting lymph node metastasis in papillary thyroid cancer

Retrospective Study of BRAFV600E Mutation and CT Features of Papillary Thyroid Carcinoma

Association between the BRAF V600E mutation and ultrasound features of the thyroid in thyroid papillary carcinoma.

[Correlation Between Ultrasound-guided Fine-needle Aspiration Combined with BRAF V600EDetection and Invasive Pathological Features of Papillary Thyroid Cancer].

Ultrasound validation of predictive model for central cervical lymph node metastasis in papillary thyroid cancer on BRAF .

Prediction of Cervical Lymph Node Metastasis with Contrast-Enhanced Ultrasound and Association Between Presence of BRAFV600E and Extrathyroidal Extension in Papillary Thyroid Carcinoma